Author(s): Bode KA, Dalpke AH
Abstract Share this page
Abstract In this issue of Blood, Roger and colleagues present data on the magnitude of influence that broad-spectrum HDAC inhibitors exert on TLR-driven immune responses, thus demonstrating that HDAC inhibitors are immunosuppressive drugs.
This article was published in Blood
and referenced in Journal of Diabetes & Metabolism